Shares of GSK rallied for a third straight day on Tuesday to hit a new all-time high, as investors gobbled up shares in ...

By Alun John, Danilo Masoni, Dimitri Rhodes and Maggie Fick LONDON (Reuters) -European and U.S. healthcare stocks surged on ...

WASHINGTON >> Pfizer and President Donald Trump on Tuesday said they had cut a deal in which the U.S.-based drugmaker agreed to lower prescription drug prices in the Medicaid program to what it ...

Despite the U.S. federal government officially shutting down after the Senate failed to reach an agreement on a last-minute spending bill, European stocks closed ...

The FTSE 100 reached a new record high as healthcare stocks soared. AstraZeneca and GSK led gains, while real estate ...

Outgoing CEO Walmsley's bold R&D push ignites investor buzz as AstraZeneca and GSK shares jump on deal optimism ...

Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...

GENEVA (Reuters) -Swiss drugmakers could strike their own deals with the U.S. after President Donald Trump's push to lower ...

GSK CEO Emma Walmsley will step down in 2025, with Luke Miels taking over as the company refocuses on pipeline growth and Montco operations.

The pound was quoted higher at USD1.3477 at the time of the London equity market close on Wednesday, compared to USD1.3443 on Tuesday. The euro stood at USD1.1729, up slightly against USD1.1727.

London's FTSE 100 brightened on Wednesday, closing 1.12% higher, after Pfizer's drug prices agreement with the US government ...

A deal between Pfizer and former President Donald Trump is sending shockwaves through both the healthcare industry and Washington — ...